Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
45.70
-0.06 (-0.13%)
Nov 21, 2024, 4:00 PM EST - Market closed

Halozyme Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for HALO stock have an average target of 61.11, with a low estimate of 49 and a high estimate of 73. The average target predicts an increase of 33.72% from the current stock price of 45.70.

Analyst Consensus: Buy
Target Low Average Median High
Price $49 $61.11 $62 $73
Change +7.22% +33.72% +35.67% +59.74%

Analyst Ratings

The average analyst rating for HALO stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 223333
Buy 444322
Hold 222344
Sell 000000
Strong Sell 000000
Total 889999

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$68
Strong Buy Reiterates $68 +48.80% Nov 20, 2024
Piper Sandler
Piper Sandler
Hold
Maintains
$51$52
Hold Maintains $51$52 +13.79% Nov 4, 2024
JMP Securities
JMP Securities
Buy
Maintains
$72$73
Buy Maintains $72$73 +59.74% Nov 1, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$65$68
Strong Buy Maintains $65$68 +48.80% Nov 1, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$65
Strong Buy Reiterates $65 +42.23% Oct 25, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
1.02B
from 829.25M
Increased by 23.36%
Revenue Next Year
1.18B
from 1.02B
Increased by 15.15%
EPS This Year
4.24
from 2.10
Increased by 101.73%
EPS Next Year
4.93
from 4.24
Increased by 16.44%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
195.99M267.59M443.31M660.12M829.25M1.02B1.18B1.43B
Revenue Growth
29.06%36.53%65.67%48.91%25.62%23.36%15.15%21.39%
EPS
-0.500.912.741.442.104.244.936.40
EPS Growth
--201.10%-47.45%45.83%101.73%16.44%29.74%
Forward PE
-----10.799.267.14
No. Analysts -----12119
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 1.1B 1.3B 1.6B
Avg 1.0B 1.2B 1.4B
Low 964.1M 1.1B 1.3B

Revenue Growth

Revenue Growth 20242025202620272028
High
28.5%
27.7%
34.9%
Avg
23.4%
15.2%
21.4%
Low
16.3%
7.8%
12.2%

EPS Forecast

EPS 20242025202620272028
High 4.41 5.67 7.83
Avg 4.24 4.93 6.40
Low 4.00 4.51 5.67

EPS Growth

EPS Growth 20242025202620272028
High
110.0%
33.8%
58.8%
Avg
101.7%
16.4%
29.7%
Low
90.4%
6.4%
15.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.